EMEA-000292-PIP01-08-M03
Key facts
| Invented name |
Glybera
|
| Active substance |
alipogene tiparvovec
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0285/2016
|
| PIP number |
EMEA-000292-PIP01-08-M03
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of hyperchylomicronaemia
|
| Route(s) of administration |
Intramuscular use
|
| Contact for public enquiries |
uniQure biopharma B.V.
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|